Lecture 38 Flashcards
Muscarinic Antagonists - Feng
1
Q
Cholinergic Blocking Drugs
A
- Used in conditions that require reduced cholinergic stimulation
- Bind to ChR but have little to no effect, prevents binding of cholinergic agonists
- Two major categories: Muscarinic and Nicotinic Antagonists
- High affinity for ChR and decreased numbers of free receptors
- Similar to ACh but with additional substituents that enhance their binding to ChR
2
Q
Natural Mus. Antagonists
A
- Tertiary amine, alkaloid, ester of tropic acid: atropine or scopolamine
- Can cross BBB as free bases
- Become protonated and antagonize mus. receptors
- CNS effects at high doses include hallucinations
- In atropine, also see restlessness, agitation, and hyperactivity
3
Q
Scopolamine
A
- Epoxy group
- Source - thorn apple
- Used to treat motion sickness
- More CNS effects (including amnesia) than atropine due to increased lipid solubility
4
Q
Atropine
A
- Racemic form of hyoscyamine
- Source - roots of belladonna (deadly nightshade)
- Similar affinity for various mus. receptor subtypes
- Used medically to decrease GI motility, dilate pupils, and as a AntiChE poisoning antidote
- L- is the main effects and D- is weakly active, so combined the mixture is intermediately active
5
Q
Organophosphate Poisoning + Atropine
A
- ACh released from terminal
- ACh crosses synaptic cleft and binds with receptor
- Nerve agents block AChE ability to stop ACh action
- Atropine blocks the receptor so ACh can’t work, no direct affect on nerve agent or AChE (counteracts chol. excess instead)
6
Q
Atropine v.s. ACh
A
- Similarities - charged nitrogen and ester group
- Differences - Aromatic ring = extra binding group (hallmark)
- Atropine is bigger than ACh, so can bind regions not usually interacting with by ACh, so induced fit doesn’t occur and therefore neither does activation
- Differ from Scopolamine by not having epoxide in positions 6 & 7
7
Q
Atropine Analogs
A
- Ipratropium (1986) and Atropine Methonitrate
- Ipratropium - bronchodilator and antiasthamtic
- Atropine methonitrate - decreases GI motility
- Quat. salts made to decrease CNS effects of Atropine
8
Q
Antimus. + Bronchial Asthma
A
- Ipratropiun Bromide and Tiotropium Bromide
- M3 receptors - cause bronchiole constriction
- Therapeutic use - block M3 receptor bronchoconstriction and allow for adrenergic bronchiole dilation to help overcome pulmonary constriction of asthma attacks
9
Q
Ipratropium Bromide
A
- Atrovent
- N-isopropyl analog of Atropine
- Highly hydrophilic and poor absorption from lungs
- Local, site specific with little systemic circulation
- Indication: bronchospasm relief with COPD
- Duration: 4 hours
10
Q
Tiotropium Bromide
A
- Spiriva
- Dithienyl derrivative of N-Methyl scopolamine
- Indication: bronchospasm relief with COPD
- Site specific, local medication
- Longer duration than ipratropium (24 hours)
- Metabolized by CYP3A4 and CYP2D6, then undergoes glutathione conjugation to form various metabolites
11
Q
Synthetic Muscarinic Antagonists
A
- Atropine is the prototype that stands as the basis for other derivatives. Derivatives aim to:
1. Overcome CNS effects
2. Archieve selectivity of Mus. receptor subtypes
3. Specific drug administration
12
Q
Mus. Antagonist Structure Requirements
A
- R1 = usually second aryl group or carbocyclic group
- R2 - usually tertiary hydroxyl or hydroxymethyl group, increase potency by hydrogen bonding with receptor
- X - ester or ether in most drugs
- Cationic amine (tertiary or quat.) with small alkyl substituents
13
Q
Quat. Ammonium Antagonists
A
- Propantheline chloride
- Pharmacore: ester + amine + aromatic ring
14
Q
Glycopyrrolate
A
- Mus. anticholinergic group
- Synthetic quat. amine, no CNS effects, doesn’t cross BBB
- Approved in 2018 by FDA to treat excessive underarm sweat
15
Q
Tertiary Amine Antagonist
A
- Benztropine (1954) and Oxyphencyclimine (1958)
- Better absorbed and distributed by all routes of admin.
- Useful for systemic delivery
- Useful in CNS disorders: Bentropine is used for Parkinsons
- Pharmacore: ester + amine + aromatic ring
16
Q
Benadryl
A
- Antihistamine
- SE: fatigue, sedation, and dizziness
- Fits relatively well to be antichol. agent, can penetrate BBB due to relative lipophilicity
17
Q
Amino ether/Amino alcohol analogs
A
- Procyclidine - 1955, amino alcohol, no ester/ether
- Orphenadine - 1959, amino ether, centrally acting muscle relaxant
- Pharmacore - Oxygen group + amine + aromatic ring
18
Q
Selective Mus. Antagonists
A
- Most mus. antagonists are also nicotine receptor antagonists at high doses
- No selectivity for M1 and M2 subtypes usually
- Pirenzepine - high affinity for M1, GI ulcer, 1 huge ring group
- AFDX 116 - Cardiac M2 binding, branching of ring is important
19
Q
SAR- Muscarinic Antagonists
A
- Tertiary or quat. nitrogen (ionized)
- Ester - preferred
- N-alkyl groups can be larger than methyl
- Large branched acyl groups - aromatic or large rings with important branching groups
20
Q
Acyl Groups
A
- Must be bulky and arranged specifically
- Must have hydrophobic regions near normal ACh binding site
- Needs to be T or Y shaped
21
Q
SAR: Agonists versus Antagonists
A
- Alkyl groups can be larger than methyls
- N can be tertiary OR quat.
- Very large acyl groups allowed, this point is MOST crucial to determining if compound will be an antagonist or not
- Not as strict as agonist group since it just needs to bind with receptor, doesn’t need to elicit a reaction
22
Q
Propantheline Chloride
A
- ACh skeleton with hydrophobic acyl side, binds more strongly than ACh itself
- Extra binding - no response induced
- Antagonist binding means ACh can’t bind
23
Q
Physicochemical and PK Parameters
A
- Antichol. are effective orally and parenterally
- Quat ammonium are not well absorbed, local effects, many available has inhalants for asthma
- Tertiary N cross BBB and absorbed orally or transdermally (Scopolamine)
24
Q
Metabolism
A
- Most ester-containing antichol. are susceptible to hydrolysis to inactivated products
- Toviaz is an exception, activated by hydrolysis
- N-dealkylation also common reaction resulting in activation
- Dose adjustments required when given with drugs that increase or decrease CYP-catalyzed reactions
25
Q
Fesoferodine
A
- Toviaz
- M3-selective drug for overactive bladder
- Prodrug, activated by plasma esterases into active metabolite, desfesoterodine